CN109692231A - The drug for treating chronic glomerulonephritis - Google Patents
The drug for treating chronic glomerulonephritis Download PDFInfo
- Publication number
- CN109692231A CN109692231A CN201710998548.3A CN201710998548A CN109692231A CN 109692231 A CN109692231 A CN 109692231A CN 201710998548 A CN201710998548 A CN 201710998548A CN 109692231 A CN109692231 A CN 109692231A
- Authority
- CN
- China
- Prior art keywords
- drug
- chronic glomerulonephritis
- treating chronic
- herb
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The present invention discloses a kind of drug for treating chronic glomerulonephritis, consists of the following compositions: Pachyrhizua angulatus 10g-20g, herba taxilli 15g-30g, Indian Epimeredi Herb 5g-8g, witchweed 5g-6g, Common Achyranthes Herb 12g-15g, saussurea involucrata 8g-10g, uncaria 3g-5g, Radix Melastomae 4g-9g, winter jasmine 16g-25g and berba aristolochiae mollissimae 1g-3g.The beneficial effects of the present invention are: chronic glomerulonephritis can be effectively treated, quick, crowd that is without side-effects and being suitable for each age group and different sexes.
Description
Technical field
The invention belongs to drug fields, and in particular to a kind of drug for treating chronic glomerulonephritis.
Background technique
Chronic glomerulonephritis is a kind of common, multiple and all age group, healing and its troublesome illness.Currently,
In the presence of the drugs of many treatment chronic glomerulonephritis, but mostly the not so good and many drug of curative effect can generate it is certain
Side effect.With the development of society, these drugs are no longer satisfied disease Man's Demands.
Summary of the invention
The technical problems to be solved by the invention are in view of the above shortcomings of the prior art, to provide and a kind of treat chronic renal
The drug of bead ephritis can easily treat chronic glomerulonephritis and without side-effects.
The technical scheme adopted by the invention is that: a kind of drug for treating chronic glomerulonephritis consists of the following compositions:
Pachyrhizua angulatus 10g-20g, herba taxilli 15g-30g, Indian Epimeredi Herb 5g-8g, witchweed 5g-6g, Common Achyranthes Herb 12g-15g, saussurea involucrata 8g-
10g, uncaria 3g-5g, Radix Melastomae 4g-9g, winter jasmine 16g-25g and berba aristolochiae mollissimae 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: chronic glomerulonephritis can be effectively treated, it is quick, it is without side-effects and applicable
In the crowd of each age group and different sexes.
Specific embodiment
Below in conjunction with specific embodiment, invention is further described in detail.
A kind of drug for treating chronic glomerulonephritis, consists of the following compositions:
Pachyrhizua angulatus 10g-20g, herba taxilli 15g-30g, Indian Epimeredi Herb 5g-8g, witchweed 5g-6g, Common Achyranthes Herb 12g-15g, saussurea involucrata 8g-
10g, uncaria 3g-5g, Radix Melastomae 4g-9g, winter jasmine 16g-25g and berba aristolochiae mollissimae 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: chronic glomerulonephritis can be effectively treated, it is quick, it is without side-effects and applicable
In the crowd of each age group and different sexes.
Claims (4)
1. a kind of drug for treating chronic glomerulonephritis, it is characterised in that: consist of the following compositions:
Pachyrhizua angulatus 10g-20g, herba taxilli 15g-30g, Indian Epimeredi Herb 5g-8g, witchweed 5g-6g, Common Achyranthes Herb 12g-15g, saussurea involucrata 8g-
10g, uncaria 3g-5g, Radix Melastomae 4g-9g, winter jasmine 16g-25g and berba aristolochiae mollissimae 1g-3g.
2. a kind of drug for treating chronic glomerulonephritis according to claim 1, it is characterised in that: described drug can
Decoction is made.
3. a kind of drug for treating chronic glomerulonephritis according to claim 1, it is characterised in that: described drug can
Tablet is made.
4. a kind of drug for treating chronic glomerulonephritis according to claim 1, it is characterised in that: described drug can
Capsule is made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710998548.3A CN109692231A (en) | 2017-10-20 | 2017-10-20 | The drug for treating chronic glomerulonephritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710998548.3A CN109692231A (en) | 2017-10-20 | 2017-10-20 | The drug for treating chronic glomerulonephritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109692231A true CN109692231A (en) | 2019-04-30 |
Family
ID=66226302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710998548.3A Pending CN109692231A (en) | 2017-10-20 | 2017-10-20 | The drug for treating chronic glomerulonephritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109692231A (en) |
-
2017
- 2017-10-20 CN CN201710998548.3A patent/CN109692231A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109692231A (en) | The drug for treating chronic glomerulonephritis | |
| CN109419918A (en) | A kind of drug for treating hemorrhoid | |
| CN109692218A (en) | The drug for treating chronic cor pulmonale | |
| CN109692280A (en) | A kind of drug for treating myasthenia gravis | |
| CN109692275A (en) | The drug for treating hyperthyroid heart disease | |
| CN109692260A (en) | A kind of drug for treating primary aldosteronism | |
| CN109692229A (en) | The drug for treating duodenal ulcer | |
| CN109692295A (en) | The drug for treating cold | |
| CN109419861A (en) | A kind of drug for treating tympanitis | |
| CN109692299A (en) | A kind of drug for treating diabetes | |
| CN109692215A (en) | A kind of drug for treating alpastic anemia | |
| CN109419919A (en) | A kind of drug for treating peptic ulcer | |
| CN109692237A (en) | The drug for treating coronary heart disease | |
| CN109692281A (en) | A kind of drug for treating sphagitis | |
| CN109420101A (en) | A kind of drug of systemic lupus erythematosus | |
| CN102343068A (en) | Traditional Chinese medicine preparation for treating gallstone | |
| CN109692243A (en) | The drug for treating trachoma | |
| CN109419873A (en) | A kind of drug for treating gastrorrhagia | |
| CN109692268A (en) | The drug for treating multiple sclerosis | |
| CN109692293A (en) | The drug for treating cerebrovascular sclerosis | |
| CN109692304A (en) | The drug for treating hypercortisolism | |
| CN109692287A (en) | The drug for treating dermatitis | |
| CN109692246A (en) | A kind of drug for treating motor neuron disease | |
| CN109381601A (en) | A kind of drug for treating acute gastroenteritis | |
| CN109419952A (en) | A kind of drug for treating thrombocytopenic purpura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190430 |